Real-time insights. Smarter decisions. Better trades.
🔍 Search Stocks 14 day Free Trial
BOTANIX PHARMACEUTICALS LTD (BOT)ASX AI Signals has generated 2 signal(s) for BOT during the last 90 days, indicating Moderate trading activity
Latest BOT Signals | |
| 08/05/2026 | BUY |
| 06/05/2026 | SELL |
BOT Share Price | |
| Current Price | $0.021 |
| 52 Week High | $0.310 |
| 52 Week Low: | $0.019 |
| Trading at (% of 52 Week High) | 6.77% |
Botanix Pharmaceuticals Ltd (ASX: BOT) is a clinical-stage pharmaceutical company that develops synthetic cannabinoid-based therapies for skin conditions and infectious diseases. The company focuses on creating innovative treatments for conditions such as acne and antimicrobial-resistant infections. Botanix combines proprietary drug delivery technology with established pharmaceutical expertise to advance its product pipeline.
The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.
The BUY signal is supported by potential growth in the pharmaceutical sector, but the very low current price indicates high volatility and speculative risk. Limited liquidity and market capitalization may affect price stability.
The Australian market is currently experiencing some nervousness, aligning with trends seen in other Asian markets as investors await the Federal Reserve's rate cut decision. Despite the cautious sentiment, opportunities still exist for those willing to explore beyond the major players. Penny stocks Australian shares are showing resilience as they head into Week 31 with a slight uptick, buoyed by a significant trade deal between the U.S. and European Union that promises to bring stability to global markets. In such an environment, investors often look for stocks that can offer growth potential Botanix Labs has onboarded a couple of crypto industry heavyweights as node operators for its bitcoin layer-2 network.
Mike Novogratz's digital asset financial services firm Galaxy and crypto custody specialist Fireblocks are among 16 new node operators on Botanix, the company announced on ThursdayLatest BOTANIX PHARMACEUTICALS LTD(BOT) News
ASX Penny Stocks Spotlight: Botanix Pharmaceuticals And Two More
ASX Penny Stocks: Botanix Pharmaceuticals And 2 Other Promising Picks
Galaxy, Fireblocks to Operate Nodes on Bitcoin Layer-2 Botanix
Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.
14 Day Free Trial • Cancel Anytime • Founders Price $15/month
Start My Free Trial